Pharmac backtracks on plan to fund lung cancer drug Keytruda
The move has dashed hopes that Keytruda would soon be publicly funded for lung cancer - New Zealand's biggest cancer killer. RNZ has obtained documents showing Pharmac had planned to offer a Request for Proposals, or RFP, where drug companies are asked to pitch their products and prices, but has put that on hold due to budget constraints. Chief executive Sarah Fitt told RNZ that Pharmac was concerned about rising drug prices worldwide in the Covid-19 pandemic and that it could not commit to funding the drug now - but still hoped to in the future.
Lung cancer patients and their advocates are devastated and said they had been given false hope. Keytruda is available in New Zealand but patients must fund it themselves. "So what we now have is 30 lung cancer patients continuing to die prematurely every week and you have to ask yourself, is that acceptable?" Fitt said funding a drug like Keytruda for lung cancer would have cost hundreds of millions over the next five years and Pharmac could not commit to that given the Covid-19 outbreak.
========================================================
AWESOME parenting
Who raised this delinquent? Him and his mate were on great north road soliciting a homeless woman to go buy them vapes from crescent dairy.
The woman did it for them. Just a reminder that if they get caught, they are implementing a woman that would otherwise have been completely innocent if those 2 weren't so desperate for a vape
🎉The Riddler wants to hear from you 🫵
🧩 Got a riddle that can stump your Neighbourly community? Share your brain teasers with us and watch your neighbours scratch their heads 😕🤔❓
Send us your tricky puzzles!
Loading…